Abbott Medical Devices — Net Sales decreased by 2.4% to $5.54B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.2%, from $4.90B to $5.54B. Over 4 years (FY 2021 to FY 2025), Medical Devices — Net Sales shows an upward trend with a 10.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong market demand and successful product adoption, while a decrease may signal competitive pressure or market saturation.
Represents the total revenue generated from the sale of medical devices, including cardiovascular, diabetes, and neuromo...
Standard revenue metric across all medical technology and healthcare device companies.
abt_segment_medical_devices_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.67B | $3.63B | $3.75B | $3.57B | $3.76B | $3.62B | $3.75B | $3.90B | $4.30B | $4.25B | $4.44B | $4.45B | $4.73B | $4.75B | $5.05B | $4.90B | $5.37B | $5.45B | $5.68B | $5.54B |
| QoQ Change | — | -0.9% | +3.2% | -4.9% | +5.4% | -3.8% | +3.7% | +4.0% | +10.1% | -1.1% | +4.6% | +0.2% | +6.3% | +0.3% | +6.4% | -3.1% | +9.7% | +1.5% | +4.2% | -2.4% |
| YoY Change | — | — | — | — | +2.5% | -0.5% | +0.0% | +9.4% | +14.3% | +17.5% | +18.5% | +14.2% | +10.2% | +11.7% | +13.7% | +9.9% | +13.4% | +14.8% | +12.3% | +13.2% |